Keywords
Aspirin resistance
Related factors
Diabetes
MicroRNA-19a
High-sensitivity C-reactive protein
Smoking
Submitted : 2023-06-06
Accepted : 2023-06-21
Published : 2023-07-06
Abstract
Objective: To study the related factors of aspirin resistance (AR) in acute ischemic stroke. Methods: A total of 138 patients with acute ischemic stroke treated in hospital affiliated to Xuzhou medical university from August 2016 to August 2018 were the study subjects, examine his medical data from the past. They were divided into the AR group (40 cases) and the non-AR group (98 cases) according to whether AR appears. Gender, disease history, biochemical indicators and etc. were compared between the two groups. The independent risk factors of AR were investigated using univariate analysis and logistic regression analysis. Results: 40 cases of AR occurred in 138 patients, with an incidence rate of 28.99%. Diabetes, platelet count (PLT), microRNA-19a (m iR-19a) expression, smoking, high-sensitivity C-reactive protein (hs-CRP), Low-density lipoprotein cholesterol (LDL-C), fibrinogen (FIB) and age difference between the AR group and non-AR group was statistically significant (P<0.05). Gender, hypertension, uric acid (UA), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), homocysteine (Hcy), total cholesterol (TC), and alanine aminotransferase (ALT) between the two groups were not significantly different (P>0.05). Logistic regression analysis showed that the independent risk factors for AR in acute ischemic stroke were diabetes (OR=2.773, 95%CI: 1.102~5.065, P=0.025), miR-19a (OR=3.021, 95%CI: 1.322~6.545, P=0.021), hs-CRP (OR=2.719, 95%CI: 1.301~5.022, P=0.028) and smoking (OR=1.983, 95%CI: 1.114~3.887, P=0.040). Conclusion: The incidence of AR is higher in acute ischemic stroke. Risk factors include diabetes, miR-19a expression, hs-CRP, smoking, etc. Clinical intervention measures can be taken to reduce the risk of AR and improve acute ischemic stroke prognosis.
References
Parida K, Li Q, Li H, 2018, Analysis of Risk Factors for Progressive Ischemic Stroke. Chinese Journal of Integrative Medicine on Cardio- / Cerebro-vascular Disease, 16(4): 507-508.
Li F, Liu D, Zhou L, 2020, The Incidence of Aspirin Resistance in Patients with Cerebral Small Vessel Disease and its Relationship with Long-Term Prognosis. Chinese Journal of Stroke, 15(6): 100-104.
Xiao Y, Ma L, 2018, Research Progress on Risk Factors for Aspirin Resistance. Clinical Journal of Medical Officer, 46(5): 104-107.
Division of Neurology, Chinese Medical Association, Cerebrovascular Disease Group for the Division of Neurology, 2015, Chinese Medical Association. Diagnosis and Treatment Guidelines for Acute Ischemic Stroke 2014. Chinese Journal of Neurology, 48(4): 246- 257.
Li X, Fan L, Wang Q, et al., 2015, Application of Receiver Operating Characteristic Curves to Analyze the Value of Thromboelastography in the Diagnosis of Aspirin Resistance in the Elderly. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 17(12): 1265 -1267.
Li Z, Dong M, Li S, et al., 2017, Study on the correlation between the recurrence of ischemic stroke and aspirin resistance. Journal of Apoplexy and Nervous Diseases, 2017, 34(6): 497-499.
Lei C, Cao S, Yang J, 2018, Argatroban Plus Aspirin versus Aspirin in Acute Ischemic Stroke. Neurol Res, 40(4): 1-6.
Sun G, Chen Y, Guo Z, et al., 2020, Analysis of Risk Factors for Aspirin Resistance in Patients with Large Atherosclerotic Cerebral Infarction. Neural Injury and Functional Reconstruction, 15(4): 12-15.
Czech MP, 2017, Insulin Action and Resistance in Obesity and Type 2 Diabetes. Nat Med, 23(7): 804-814.
Huang H, Zheng A, Ding X, et al., 2017, Analysis of Related Factors in Patients With Type 2 Diabetes Mellitus with Aspirin Resistance. Chinese Community Physician, 33(32): 106-107.
Ma K, Sun K, Sun B, 2016, The Expression and Clinical Significance of Platelet miR-19a in Patients with Acute Cerebral Infarction and Aspirin Resistance. Anhui Medical and Pharmaceutical Journal, 20(6): 1135-1137.
Binderup HG, Houlind K, Madsen JS, et al., 2016, Aspirin Resistance maybe Identified by miR-92a in Plasma Combined with Platelet Distribution Width. Clin Biochem, 49(15): 1167-1172.
Jing L, Sun R, 2017, Research on the Mechanism of Aspirin Resistance. Journal of Brain and Nervous Diseases, 25(10): 657-660.
Zhao W, Li Q, Sun J, 2018, The Relationship between Homocysteine, Thromboelastogram and Aspirin Resistance in Patients with Cerebral Infarction. Laboratory Medicine, 33(7): 637-639.
Xu W, Chen Y, Hua W, et al., 2016, Discussion on the Rationality of Fixed Compound Preparations of Aspirin and Proton Pump Inhibitor. The Chinese Journal of Clinical Pharmacology, 32(5): 466-468.
Xie W, Chen S, 2015, The Effect of Smoking on the Efficacy of Aspirin and Clopidogrel. Medical Recapitulate, 21(14): 2604-2606.
Alicia M, Azarpazhooh MR, Munoz C, et al., 2017, Association of Homocysteine and Smoking with Cerebral Microemboli in Patients with Mechanical Heart Valves: A Transcranial Doppler Study. Stroke Vasc Neurol, 2(4): 198-203.
Zhou Y, Cao T, 2019, SGP ? as A New Diagnostic Marker for Platelet Activation and its Clinical Significance. Guangdong Medical Journal, 40(20): 2970-2973.
Guo S, 2020, Correlation Analysis between Polymorphisms of Multidrug Resistance Genes and Aspirin Resistance in Patients with Ischemic Stroke. Jilin Medical Journal, 41(6): 1354-1356.
Zhu X, Lu X, 2016, Correlation Analysis of Aspirin Resistance in Patients with Recurrent Acute Cerebral Infarction. China Pharmacy, 27(9): 1194-1196.
Wu H, Lv H, Qian J, et al., 2018, Evaluating the Effect of Smoking on the Efficacy of Dual Antiplatelet Drugs using Thromboelastography. Shanghai Medical Journal, 41(1): 9-13.
Zhao H, Bai T, Xue J, et al., 2019, Analysis of Risk Factors for Aspirin Resistance in Patients with Acute Coronary Syndrome. China Medicine, 14(11): 1614-1617.
Sun G, Chen Y, Guo Z, et al., 2020, Analysis of Risk Factors for Aspirin Resistance in Patients with Large Atherosclerotic Cerebral Infarction. Neural Injury and Functional Reconstruction, 15(4): 12-15.
Yan Q, Wang J, Liu H, et al., 2019, Analysis of Secondary Prevention Using Aspirin, Readmission Rate and Influencing Factors in 220 Patients with Coronary Heart Disease. Journal of Clinical Medicine in Practice, 23(6): 50-54.
Zuo H, Deng L, Wang J, 2018, Consistency Analysis and Application Status of Two Criteria in the Determination if the Use of Aspirin in Primary Prevention of Ischemic Cardiovascular Disease. Chinese Journal of Cardiology, 46(4): 298-303.
Zhong X, Yu T, 2020, Observation of Antiplatelet Drug Reactivity in 214 Patients with Acute Ischemic Stroke and Exploration of the Relevant Influencing Factors. Chinese Journal of Laboratory Diagnosis, 2020, 24(1): 17-20.